meddevicedb.com FDA Device Reference

LIAISON Calprotectin, LIAISON Calprotectin Control Set, LIAISON Calprotectin Calibration Verifiers, LIAISON Q.S.E.T. Buffer, LIAISON Q.S.E.T. Device

K182698 Class II Traditional
Decision Date
2018-12-26
Sponsor / Applicant
DiaSorin, Inc.

Technical Specification

510(k) Submission ID K182698
Product Code NXO
Medical Specialty / Panel Immunology
Regulation Citation 21 CFR 866.5180
Decision Date 2018-12-26
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

LIAISON Calprotectin, LIAISON Calprotectin Control Set, LIAISON Calprotectin Calibration Verifiers, LIAISON Q.S.E.T. Buffer, LIAISON Q.S.E.T. Device received FDA 510(k) clearance under submission number K182698, sponsored by DiaSorin, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2018-12-26.

Classification & Regulation

This clearance is catalogued under FDA product code NXO and 21 CFR 866.5180, within the Immunology review panel as a Class II device.